These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 5028

  • 1. [Hemodynamic study of dopamine used in chronic heart failures and in cardiogenic shock as a complication of acute myocardial infarct].
    Flammang D, Sebastien P, Bouvrain Y.
    Ann Anesthesiol Fr; 1975 Dec; 16(9):669-72. PubMed ID: 5028
    [Abstract] [Full Text] [Related]

  • 2. Hemodynamic and therapeutic effects of intravenous dopamine.
    Théroux P, Mizgala HF, Bourassa MG.
    Can Med Assoc J; 1977 Mar 19; 116(6):645-8. PubMed ID: 608165
    [Abstract] [Full Text] [Related]

  • 3. [The use of dopamin in shock and heart failure (author's transl)].
    Aroński A, Kübler A, Sliwinski M, Paszkowska A.
    Anaesthesist; 1978 Apr 19; 27(4):183-6. PubMed ID: 655365
    [Abstract] [Full Text] [Related]

  • 4. [Dopamine in patients with cardiogenic shock (author's transl)].
    Kikis D, Esser H, Trübestein G.
    Med Klin; 1977 Jul 15; 72(28-29):1212-7. PubMed ID: 329088
    [Abstract] [Full Text] [Related]

  • 5. [Catecholamines in internal medicine emergencies].
    Brandt D, Pristautz H, Klein W.
    Wien Med Wochenschr; 1984 Jul 31; 134(13-14):324-7. PubMed ID: 6495745
    [Abstract] [Full Text] [Related]

  • 6. [Use of dopamine in the treatment of cardiogenic shock. Preliminary results].
    Chiche P, Baligadoo S.
    Ann Anesthesiol Fr; 1975 Dec 31; 16(9):705-10. PubMed ID: 5034
    [Abstract] [Full Text] [Related]

  • 7. [First experiences with the use of dopamine (hydroxytyramine) in cardiogenic shock].
    Döring D, Fleischmann HJ, Heunisch K, Köhler H, Trenckmann H.
    Z Gesamte Inn Med; 1971 Dec 15; 26(24):759-63. PubMed ID: 5152441
    [No Abstract] [Full Text] [Related]

  • 8. [Hemodynamics of the insufficient heart following myocardial infarct during diuresis with furosemide].
    Bachour G, Hochrein H, Wolf R, Beck OA, Helwing HP.
    Z Kardiol; 1974 Dec 15; 63(12):1077-86. PubMed ID: 4458322
    [No Abstract] [Full Text] [Related]

  • 9. [Hemodynamic aspects of differential therapy of acute myocardial infarct with nitrates].
    Lehmann HU, Hochrein H.
    Z Kardiol; 1985 Dec 15; 74 Suppl 1():23-9. PubMed ID: 3993161
    [No Abstract] [Full Text] [Related]

  • 10. Inotropic therapy for cardiac low output syndrome: comparison of hemodynamic effects of dopamine/dobutamine versus dopamine/dopexamine.
    El Mokhtari NE, Arlt A, Meissner A, Lins M.
    Eur J Med Res; 2007 Nov 05; 12(11):563-7. PubMed ID: 18024265
    [Abstract] [Full Text] [Related]

  • 11. Thrombolytic therapy in cardiogenic shock: effect of increased aortic pressure and rapid tPA administration.
    Garber PJ, Mathieson AL, Ducas J, Patton JN, Geddes JS, Prewitt RM.
    Can J Cardiol; 1995 Jan 05; 11(1):30-6. PubMed ID: 7850662
    [Abstract] [Full Text] [Related]

  • 12. Hemodynamic effects of levosimendan in acute myocardial infarction complicated by cardiogenic shock and high systemic vascular resistance.
    Tsagalou EP, Kanakakis J, Anastasiou-Nana MI, Drakos SG, Ntalianis AS, Malliaras K, Lazaris N, Katsaros F, Nanas JN.
    Acute Card Care; 2009 Jan 05; 11(2):99-106. PubMed ID: 19353405
    [Abstract] [Full Text] [Related]

  • 13. [Differential therapy of cardiogenic shock with dopamine/milrinone in comparison with dopamine/dobutamine].
    Meissner A, Schmelzle T, Simon R.
    Z Kardiol; 1996 Nov 05; 85(11):839-46. PubMed ID: 9064946
    [Abstract] [Full Text] [Related]

  • 14. Pharmacologic support in cardiogenic shock.
    Rude RE.
    Adv Shock Res; 1983 Nov 05; 10():35-49. PubMed ID: 6349299
    [Abstract] [Full Text] [Related]

  • 15. [Cardiovascular effects of hydroxytyramine (dopamine) and its importance for the therapy of cardiogenic shock in heart infarct. 2. Experimental studies on hypodynamic hearts of dogs].
    Urbaszek W, Günther K, Trenckmann H, Döring D.
    Z Gesamte Inn Med; 1970 Apr 01; 25(7):290-3. PubMed ID: 4398843
    [No Abstract] [Full Text] [Related]

  • 16. [Dopamine and shock. Preliminary clinical study of 7 cases].
    Dubouloz F, Martin C, Fogliani J, Nava G.
    Ann Anesthesiol Fr; 1975 Dec 01; 16(9):701-3. PubMed ID: 5033
    [Abstract] [Full Text] [Related]

  • 17. Effectiveness of dopamine in patients with cardiogenic shock.
    Holzer J, Karliner JS, O'Rourke RA, Pitt W, Ross J.
    Am J Cardiol; 1973 Jul 01; 32(1):79-84. PubMed ID: 4713114
    [No Abstract] [Full Text] [Related]

  • 18. [Hemodynamics after prindolol and digitalis in acute myocardial infarction (author's transl)].
    Bachour G, Bender F, Hochrein H.
    Med Klin; 1976 Mar 05; 71(10):414-20. PubMed ID: 57564
    [Abstract] [Full Text] [Related]

  • 19. Use of catecholamines in acute myocardial infarction.
    Dixon DW, Loeb HS, Gunnar RM.
    Herz; 1979 Oct 05; 4(5):385-96. PubMed ID: 391685
    [Abstract] [Full Text] [Related]

  • 20. Use of nitroglycerin in the treatment of acute heart failure and cardiogenic shock in patients with myocardial infarction.
    Belskii NE, Pilipenko VA, Roshchin SI, Shira AI, Gilmar IS.
    Cor Vasa; 1987 Oct 05; 29(2):89-97. PubMed ID: 3109805
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.